α1肾上腺素能受体拮抗剂在提示良性前列腺增生的下尿路症状患者中的疗效和耐受性的研究现状 - Suppr

Suppr

超能文献

State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

作者信息

Djavan Bob, Chapple Chris, Milani Shirin, Marberger Michael

机构信息

Department of Urology, University of Vienna, Vienna, Austria.

出版信息

Urology. 2004 Dec;64(6):1081-8. doi: 10.1016/j.urology.2004.07.031.

DOI:10.1016/j.urology.2004.07.031

PMID:15596173

Abstract

摘要

相似文献

State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.α1肾上腺素能受体拮抗剂在提示良性前列腺增生的下尿路症状患者中的疗效和耐受性的研究现状

Urology. 2004 Dec;64(6):1081-8. doi: 10.1016/j.urology.2004.07.031.

[Progress in the studies of alpha1-receptor blocker for benign prostatic hyperplasia].[α1受体阻滞剂治疗良性前列腺增生症的研究进展]

Zhonghua Nan Ke Xue. 2004 Jul;10(7):483-5.

Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.新型α₁-肾上腺素能受体拮抗剂在治疗良性前列腺增生相关下尿路症状中的作用。

Clin Ther. 2004 Nov;26(11):1701-13. doi: 10.1016/j.clinthera.2004.11.006.

Alpha1 adrenergic receptor blockade in the male lower urinary tract and other body systems.α1肾上腺素能受体阻断在男性下尿路及其他身体系统中的作用

Scand J Urol Nephrol Suppl. 1995;168:13-9.

(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).（苯基哌啶基）环己基磺酰胺：用于治疗良性前列腺增生/下尿路症状（BPH/LUTS）的α1a/1d选择性肾上腺素能受体拮抗剂的研发

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3930-4. doi: 10.1016/j.bmcl.2007.04.098. Epub 2007 May 3.

Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia.α1A -肾上腺素能受体基因多态性不会改变α1 -肾上腺素能受体拮抗剂治疗良性前列腺增生的短期和长期疗效。

BJU Int. 2006 Apr;97(4):852-5. doi: 10.1111/j.1464-410X.2006.05998.x.

Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia.α1-肾上腺素能受体亚型mRNA的表达作为亚型选择性α1-肾上腺素能受体拮抗剂治疗良性前列腺增生疗效的预测指标。

J Urol. 2008 Mar;179(3):1040-6. doi: 10.1016/j.juro.2007.10.082. Epub 2008 Jan 18.

[Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].α1肾上腺素能受体阻滞剂治疗良性前列腺增生合并高血压的研究进展

Zhonghua Nan Ke Xue. 2007 Sep;13(9):830-4.

Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.两种α1肾上腺素能受体拮抗剂萘哌地尔和盐酸坦索罗辛治疗良性前列腺增生所致下尿路症状的比较：一项随机交叉研究。

BJU Int. 2006 Apr;97(4):747-51, discussion 751. doi: 10.1111/j.1464-410X.2006.06030.x.

The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation.各种α1-肾上腺素能受体拮抗剂对瞳孔散大的作用。

Ann Ophthalmol (Skokie). 2008 Spring;40(1):19-21.

引用本文的文献

The efficacy of pyridostigmine therapy after transurethral resection of prostate in cases with underactive urinary bladder: prospective randomized trial.经尿道前列腺切除术后膀胱功能低下患者使用吡啶斯的明治疗的疗效：前瞻性随机试验。

World J Urol. 2025 Aug 2;43(1):473. doi: 10.1007/s00345-025-05842-8.

Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis.商业口服多草药中药配方联合西药治疗良性前列腺增生的比较疗效：一项系统评价和网状Meta分析

Front Pharmacol. 2024 Jun 5;15:1358340. doi: 10.3389/fphar.2024.1358340. eCollection 2024.

Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention.坦索罗辛 0.8 毫克每日剂量治疗坦索罗辛 0.4 毫克单药治疗失败且不适合手术干预的 BPH 患者。

World J Urol. 2024 Jun 1;42(1):365. doi: 10.1007/s00345-024-05050-w.

Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.良性前列腺梗阻的治疗算法：当前技术概述

Life (Basel). 2023 Oct 18;13(10):2077. doi: 10.3390/life13102077.

Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review.老年有跌倒风险的良性前列腺增生患者抗毒蕈碱药物和α受体阻滞剂的应用管理：临床评价。

Eur Geriatr Med. 2023 Aug;14(4):733-746. doi: 10.1007/s41999-023-00798-7. Epub 2023 May 28.

Efficacy of 1-Year Cavacurmin Therapy in Reducing Prostate Growth in Men Suffering from Lower Urinary Tract Symptoms.1年卡瓦胡椒素疗法对减轻下尿路症状男性前列腺增生的疗效。

J Clin Med. 2023 Feb 20;12(4):1689. doi: 10.3390/jcm12041689.

Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing.α1 肾上腺素受体拮抗剂在老年人群中的疗效和安全性：一项系统评价和荟萃分析，支持制定减少潜在不适当处方的建议。

BMC Geriatr. 2022 Sep 28;22(1):771. doi: 10.1186/s12877-022-03415-7.

Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases.选择性α-1阻滞剂术中虹膜松弛综合征的风险——6488例病例的一致性模型

Front Med (Lausanne). 2022 Aug 30;9:941130. doi: 10.3389/fmed.2022.941130. eCollection 2022.

Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.良性前列腺梗阻的药物及介入治疗：一项基于证据的比较性综述

BJUI Compass. 2021 Feb 3;2(4):238-259. doi: 10.1002/bco2.74. eCollection 2021 Jul.

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary).印度泌尿外科学会关于良性前列腺增生/良性前列腺梗阻管理的指南（执行摘要）

Indian J Urol. 2021 Jul-Sep;37(3):210-213. doi: 10.4103/iju.iju_121_21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验